Norberto Batista López

1.8k total citations
5 papers, 208 citations indexed

About

Norberto Batista López is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Norberto Batista López has authored 5 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Oncology. Recurrent topics in Norberto Batista López's work include Chronic Lymphocytic Leukemia Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and HER2/EGFR in Cancer Research (1 paper). Norberto Batista López is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and HER2/EGFR in Cancer Research (1 paper). Norberto Batista López collaborates with scholars based in Spain, Australia and United States. Norberto Batista López's co-authors include Miguel Martín, Alexey Manikhas, Manuel Ramos Vázquez, Petr Krivorotko, Patrick Urban, Suzette Delaloge, Manuel Ruíz Borrego, Julia Beck, Mario Campone and Qamar J. Khan and has published in prestigious journals such as Annals of Oncology, Oncotarget and Molecular Cancer Therapeutics.

In The Last Decade

Norberto Batista López

5 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norberto Batista López Spain 4 112 90 79 36 35 5 208
Eiman Ibrahim United States 7 46 0.4× 172 1.9× 65 0.8× 36 1.0× 20 0.6× 17 270
Songfeng Zhao China 8 100 0.9× 49 0.5× 53 0.7× 23 0.6× 70 2.0× 18 255
Juliette Sailland United States 8 137 1.2× 37 0.4× 92 1.2× 12 0.3× 34 1.0× 8 302
C. O'Callaghan United States 10 143 1.3× 104 1.2× 55 0.7× 9 0.3× 59 1.7× 14 360
Wilhelm Geilen Germany 6 71 0.6× 49 0.5× 44 0.6× 15 0.4× 18 0.5× 6 240
Torsten Holm Nielsen Denmark 8 71 0.6× 50 0.6× 23 0.3× 25 0.7× 26 0.7× 31 253
Kathy Brown United States 6 100 0.9× 139 1.5× 24 0.3× 46 1.3× 79 2.3× 8 392
Tomoko Nukui United States 10 163 1.5× 110 1.2× 95 1.2× 10 0.3× 71 2.0× 17 349
Alberto Fulvi Italy 5 59 0.5× 135 1.5× 99 1.3× 5 0.1× 19 0.5× 6 211
Abdolazim Sedighi Pashaki Iran 11 185 1.7× 80 0.9× 76 1.0× 13 0.4× 150 4.3× 26 347

Countries citing papers authored by Norberto Batista López

Since Specialization
Citations

This map shows the geographic impact of Norberto Batista López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norberto Batista López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norberto Batista López more than expected).

Fields of papers citing papers by Norberto Batista López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norberto Batista López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norberto Batista López. The network helps show where Norberto Batista López may publish in the future.

Co-authorship network of co-authors of Norberto Batista López

This figure shows the co-authorship network connecting the top 25 collaborators of Norberto Batista López. A scholar is included among the top collaborators of Norberto Batista López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norberto Batista López. Norberto Batista López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Martín, Miguel, Luc Dirix, Joyce O’Shaughnessy, et al.. (2016). A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2– advanced breast cancer (BELLE-4). Annals of Oncology. 28(2). 313–320. 136 indexed citations
2.
Martín, Miguel, Arlene Chan, Luc Dirix, et al.. (2015). Abstract A166: BELLE-4: A Phase II study of buparlisib and paclitaxel in women with HER2- advanced breast cancer, with or without PI3K pathway activation. Molecular Cancer Therapeutics. 14(12_Supplement_2). A166–A166. 1 indexed citations
3.
Cufí, Sílvia, Bruna Corominas-Faja, Eugeni López‐Bonet, et al.. (2013). Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin. Oncotarget. 4(9). 1484–1495. 28 indexed citations
4.
López, Norberto Batista, et al.. (2006). Oncologists’ perceptions of cancer pain management in Spain: The real and the ideal. European Journal of Pain. 11(3). 352–359. 13 indexed citations
5.
Santolaria, Francisco, et al.. (1994). ALCOHOLIC WITHDRAWAL SYNDROME AND SEIZURES. Alcohol and Alcoholism. 29(3). 323–8. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026